Ocular Therapeutix (OCUL) Gross Margin (2016 - 2025)
Historic Gross Margin for Ocular Therapeutix (OCUL) over the last 12 years, with Q4 2025 value amounting to 2.21%.
- Ocular Therapeutix's Gross Margin fell 343300.0% to 2.21% in Q4 2025 from the same period last year, while for Dec 2025 it was 3.79%, marking a year-over-year decrease of 385300.0%. This contributed to the annual value of 3.79% for FY2025, which is 385300.0% down from last year.
- According to the latest figures from Q4 2025, Ocular Therapeutix's Gross Margin is 2.21%, which was down 343300.0% from 10.01% recorded in Q3 2025.
- Ocular Therapeutix's 5-year Gross Margin high stood at 39.21% for Q2 2024, and its period low was 32.25% during Q1 2025.
- For the 5-year period, Ocular Therapeutix's Gross Margin averaged around 19.57%, with its median value being 25.47% (2021).
- In the last 5 years, Ocular Therapeutix's Gross Margin surged by 3205500bps in 2021 and then tumbled by -633200bps in 2025.
- Quarter analysis of 5 years shows Ocular Therapeutix's Gross Margin stood at 25.77% in 2021, then dropped by -2bps to 25.17% in 2022, then skyrocketed by 49bps to 37.54% in 2023, then decreased by -3bps to 36.54% in 2024, then plummeted by -94bps to 2.21% in 2025.
- Its Gross Margin stands at 2.21% for Q4 2025, versus 10.01% for Q3 2025 and 2.01% for Q2 2025.